Uranium Energy Corp. reported zero revenue for its fiscal third quarter, a deliberate strategy as the company stockpiles production while waiting for higher uranium prices. The decision backfired on the stock, which plunged 18% in a single session and has lost 27% over the past month, landing 45% below its 52-week high.
The net loss came in at $0.11 per share, more than triple the $0.03 deficit analysts had penciled in. The company produced roughly 32,200 pounds of uranium concentrate during the quarter at direct cash costs of $46.69 per pound — elevated due to permitting delays at its Burke Hollow project in Texas, the largest new US uranium mine to start up in over a decade. Management sold not a single gram of the metal, instead adding output to a growing inventory that now stands at around 1.45 million pounds, worth about $127 million at current spot prices.
The operating loss is underwritten by an exceptionally strong balance sheet. Uranium Energy holds $794 million in cash and equivalents and carries no debt. That war chest allows management to eschew hedging and forward sales entirely, betting that the spot market will eventually deliver prices high enough to monetize the accumulated stockpile at a tidy profit. For now, the cash pile covers the cost of waiting, though the stock’s 100% plus volatility has tested investor patience.
Should investors sell immediately? Or is it worth buying Uranium Energy?
On the expansion front, the company is pushing toward becoming an integrated nuclear fuel supplier. It recently secured a docket number from the US Nuclear Regulatory Commission for a planned uranium conversion facility, and design work continues with engineering partner Fluor. Site selection is under way, with the US Department of Energy involved in the discussions. A final decision on the conversion plant is not expected until 2027. Additional policy support came in April 2026 when the DOE launched its “Nuclear Dominance — 3 by 33” campaign, targeting a secure domestic nuclear fuel supply chain by 2033 — a long-term tailwind for the largest holder of US uranium resources.
Wall Street analysts remain broadly constructive despite the earnings miss. Goldman Sachs trimmed its price target to $16 from a prior level but maintained a buy rating. H.C. Wainwright reiterated its buy recommendation with a $26.75 target. At its current trading price of €9.54, the stock offers substantial upside if those forecasts prove accurate.
The next catalyst arrives with fiscal fourth-quarter results, when the company will book a full quarter of production from the newly ramped Burke Hollow operation. If Uranium Energy finally starts selling some of its inventory at improved market prices, the bulls will have fresh ammunition to reverse the stock’s recent slide.
Ad
Uranium Energy Stock: Buy or Sell?! New Uranium Energy Analysis from June 14 delivers the answer:
The latest Uranium Energy figures speak for themselves: Urgent action needed for Uranium Energy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.
Uranium Energy: Buy or sell? Read more here...
